• Ginsenoside Rg6 Reverses Cisplatin Resistance via ERK1/2-mTO

  2026-05-21

  The referenced study reveals that ginsenoside Rg6 improves cisplatin resistance in epithelial ovarian cancer cells by suppressing protein fucosylation and inducing autophagy through inhibition of the GRB2–ERK1/2–mTOR pathway. These findings highlight a promising adjuvant strategy for overcoming drug resistance in ovarian cancer treatment.

• Ibotenic Acid: Advancing Translational Neurodegeneration Mod

  2026-05-21

  This thought-leadership article explores ibotenic acid’s mechanistic value as an NMDA receptor agonist, strategic deployment in animal models of neurodegenerative disorders, and the translational implications for next-generation preclinical research. Integrating recent evidence on dose-dependent neurotoxicity and best-practice protocol design, the piece provides actionable guidance for researchers seeking to leverage high-purity ibotenic acid from APExBIO to achieve reproducible, disease-relevant neurocircuit interrogation.

• Vitamin C as an Anticancer Agent: Protocols and Organoid App

  2026-05-20

  Vitamin C (ascorbic acid) is reshaping preclinical oncology and virology by offering potent, reproducible antiproliferative and apoptosis-inducing effects. This guide bridges advanced organoid workflows with practical troubleshooting and protocol optimization, making APExBIO’s high-purity Vitamin C a cornerstone for next-generation cancer research.

• Ionomycin Calcium Salt: Precision Tools for Dissecting Calci

  2026-05-20

  Explore how Ionomycin calcium salt, a leading calcium ionophore, enables cutting-edge dissection of calcium signaling pathways in cancer biology and cell physiology. This article uniquely connects molecular mechanisms to real-world assay optimization and emerging therapeutic insights.

• iPSC-Derived Multilineage Organoids Enable Pan-Tissue HEV St

  2026-05-19

  This study establishes iPSC-induced human liver, intestinal, and brain organoids as comprehensive in vitro platforms for modeling hepatitis E virus (HEV) infection and replication across multiple human-relevant tissues. The work advances mechanistic understanding of HEV tropism, pathogenesis, and antiviral response, providing a physiologically relevant alternative to traditional models for antiviral research.

• Reactive Oxygen Species Assay Kit: Advanced DHE Probe Workfl

  2026-05-19

  The Reactive Oxygen Species Assay Kit (DHE) is optimized for sensitive, reproducible detection of intracellular superoxide, unlocking new precision in oxidative stress and apoptosis research. Discover robust protocol parameters, advanced troubleshooting, and insights from cutting-edge immunomodulatory studies to elevate your redox biology experiments.

• Superoxide Dismutase (SOD) Activity Assay Kit: Practical Gui

  2026-05-18

  The Superoxide Dismutase (SOD) Activity Assay Kit addresses the need for accurate, rapid quantification of SOD enzyme activity in biological fluids and cell extracts, supporting research into oxidative stress and antioxidative capacity. It is not intended for diagnostic, clinical, or mechanistic pathway studies. Researchers should employ this kit for robust colorimetric SOD quantification within validated laboratory workflows.

• Ertapenem (sodium salt): Reliable Solutions for Antibacteria

  2026-05-18

  This article delivers scenario-driven, evidence-based guidance for optimizing cell viability and resistance assays using Ertapenem (sodium salt) (SKU C3451). Drawing on validated protocols and current literature, we address reproducibility, compatibility, and vendor selection for robust, data-backed workflows. Researchers will gain practical insights into maximizing assay reliability with this broad-spectrum carbapenem antibiotic.

• CRISPR-Cas9 Editing of LGMN Inhibits Breast Cancer Metastasi

  2026-05-17

  This study demonstrates that co-delivery of Cas9 mRNA and guide RNAs using lipid nanoparticles to edit the LGMN gene effectively suppresses breast cancer cell metastasis. The work highlights the necessity of precise in vitro transcription protocols for generating high-quality gRNAs and Cas9 mRNA, providing a foundational workflow for therapeutic CRISPR applications.

• Filipin III: Powering Precision Cholesterol Mapping in MASLD

  2026-05-16

  This thought-leadership article explores how Filipin III—a polyene macrolide antibiotic—enables unprecedented mechanistic insight into cholesterol regulation in metabolic dysfunction-associated steatotic liver disease (MASLD). Bridging state-of-the-art membrane cholesterol visualization with actionable guidance, this piece highlights the translational impact of Filipin III for researchers addressing cholesterol-driven liver pathology, referencing the latest evidence and best-in-class protocols.

• Thiazovivin: Technical Guide for ROCK Inhibition in Stem Cel

  2026-05-15

  Thiazovivin is a high-purity ROCK inhibitor designed to support fibroblast reprogramming and enhance the survival of human embryonic stem cells (hESCs) during stress events such as dissociation. It is best suited for advanced stem cell research workflows, but should not be applied in diagnostic or therapeutic contexts due to its research-use-only designation.

• Forsythoside E: PKM2 Inhibitor for Immunometabolic Research

  2026-05-15

  Forsythoside E stands out as a mechanistically precise pyruvate kinase M2 (PKM2) inhibitor, enabling robust immunometabolic investigations in sepsis-induced liver injury and macrophage polarization. This guide translates bench protocols, troubleshooting, and comparative innovations into actionable steps for researchers seeking reliable results.

• IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan

  2026-05-14

  This study uncovers how IGF2BP3, acting as a dominant m6A reader, stabilizes FZD1/7 transcripts to promote cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). The mechanistic findings establish a novel RNA regulatory axis as a therapeutic vulnerability, with implications for targeting cancer stem cells and improving chemotherapy outcomes.

• Omicron KP.3 RBD mRNA Vaccine: Broad Neutralization in Mice

  2026-05-14

  This study presents a newly designed mRNA vaccine encoding the Omicron KP.3 receptor-binding domain (RBD), demonstrating robust antibody responses and broad neutralization against multiple SARS-CoV-2 Omicron subvariants in mice. The work highlights both the technical advances in antigen design and the practical implications for next-generation mRNA vaccine development.

• Vitamin C in Organoid Cancer Research: Protocols and Innovat

  2026-05-13

  Vitamin C (ascorbic acid) is transforming preclinical cancer and virology research through its dual role as an apoptosis inducer and tumor proliferation inhibitor. This article guides advanced experimental design using high-purity Vitamin C in organoid and animal models, spotlighting protocol optimization, troubleshooting, and the pioneering use of multilineage organoids in antiviral discovery.

11789 records 1/786 page Next 12345 下5页 Last page